arrow
S

Sarat Chandarlapaty

Memorial Sloan Kettering Cancer Center
H指数:74
被引数:2.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Rb-driven transcription limits its tumour-suppressive effects in breast cancer

Rb驱动的转录限制其在乳腺癌中的肿瘤抑制作用

Nature
IF48.5
2026-08-120
OA
Homologous recombination deficiency and hemizygosity drive resistance in breast cancer

乳腺癌的同源重组缺陷和半合子驱动抵抗

Nature
IF48.5
2026-03-040
OAAI
Determinants of sensitivity to HER2-targeted antibody drug conjugates in urothelial cancer

尿路上皮癌对HER2靶向抗体药物偶联物的敏感性决定因素

2025-12-200
OAAI
Publisher Correction: APOBEC3 mutagenesis drives therapy resistance in breast cancer

出版商更正:APOBEC3突变驱动乳腺癌的疗法抵抗

2025-12-120
OAAI
Determinants of long-term response to patritumab deruxtecan in breast cancer patient-derived xenografts

帕利妥单抗德鲁克特肯长期疗效的决定因素:基于乳腺癌患者来源异种移植模型

2025-11-210
OAAI
Genomic landscape of breast cancer in elderly patients

老年乳腺癌患者的基因组景观

2025-07-100
OAAI
APOBEC3 mutagenesis drives therapy resistance in breast cancer

APOBEC3诱变驱动乳腺癌的疗法抗性。

2025-05-160
OA
Inhibition of NR2F2 restores hormone therapy response to endocrine refractory breast cancers

NR2F2的抑制恢复了内分泌耐药性乳腺癌对激素治疗的反应

2025-01-010
OA